publication venue for
- Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization.. 12:1227-1236. 2025
- Barriers and facilitators to implementation of intravenous cardiovascular treatments in ambulatory settings.. 12:695-700. 2025
- Epidemiology and treatment of heart failure with chronic obstructive pulmonary disease in Canadian primary care. 10:3612-3621. 2023
- Pharmaco‐disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries. 10:3152-3163. 2023
- Pharmacogenomic study of heart failure and candesartan response from the CHARM programme. 9:2997-3008. 2022
- Association of chronic heart failure with mortality in old intensive care patients suffering from Covid‐19. 9:1756-1765. 2022
- The genomics of heart failure: design and rationale of the HERMES consortium. 8:5531-5541. 2021
- Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes. 8:2741-2754. 2021
- Derivation and validation of a two‐variable index to predict 30‐day outcomes following heart failure hospitalization. 8:2690-2697. 2021
- The LENT index predicts 30 day outcomes following hospitalization for heart failure. 8:518-526. 2021
- Rationale and design of the EU‐CERT‐ICD prospective study: comparative effectiveness of prophylactic ICD implantation. 6:182-193. 2019
- Barriers to goals of care discussions with hospitalized patients with advanced heart failure: feasibility and performance of a novel questionnaire. 3:245-252. 2016